In "VEGF actu", Bernard Lévy from l’Insitut des Vaisseaux et du Sang in Paris, has highlighted our recent work on propranolol published in Oncotarget. You can view the full text article using the link bellow.
This forum is pre-moderated: your contribution will only appear after being validated by an admin.
To create paragraphs, just leave blank lines.
Please leave this field empty: